401 related articles for article (PubMed ID: 22213132)
1. Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip.
Thiel C; Rind N; Popovici D; Hoffmann GF; Hanson K; Conway RL; Adamski CR; Butler E; Scanlon R; Lambert M; Apeshiotis N; Thiels C; Matthijs G; Körner C
Hum Mutat; 2012 Mar; 33(3):485-7. PubMed ID: 22213132
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
[TBL] [Abstract][Full Text] [Related]
3. A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip.
Rind N; Schmeiser V; Thiel C; Absmanner B; Lübbehusen J; Hocks J; Apeshiotis N; Wilichowski E; Lehle L; Körner C
Hum Mol Genet; 2010 Apr; 19(8):1413-24. PubMed ID: 20080937
[TBL] [Abstract][Full Text] [Related]
4. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
[TBL] [Abstract][Full Text] [Related]
5. ALG1-CDG: a new case with early fatal outcome.
Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
[TBL] [Abstract][Full Text] [Related]
6. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.
Dupré T; Vuillaumier-Barrot S; Chantret I; Sadou Yayé H; Le Bizec C; Afenjar A; Altuzarra C; Barnérias C; Burglen L; de Lonlay P; Feillet F; Napuri S; Seta N; Moore SE
J Med Genet; 2010 Nov; 47(11):729-35. PubMed ID: 20679665
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
[TBL] [Abstract][Full Text] [Related]
8. Identification of phosphorylated oligosaccharides in cells of patients with a congenital disorders of glycosylation (CDG-I).
Vleugels W; Duvet S; Peanne R; Mir AM; Cacan R; Michalski JC; Matthijs G; Foulquier F
Biochimie; 2011 May; 93(5):823-33. PubMed ID: 21315133
[TBL] [Abstract][Full Text] [Related]
9. A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings.
Dancourt J; Vuillaumier-Barrot S; de Baulny HO; Sfaello I; Barnier A; le Bizec C; Dupre T; Durand G; Seta N; Moore SE
Pediatr Res; 2006 Jun; 59(6):835-9. PubMed ID: 16641202
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik.
Schwarz M; Thiel C; Lübbehusen J; Dorland B; de Koning T; von Figura K; Lehle L; Körner C
Am J Hum Genet; 2004 Mar; 74(3):472-81. PubMed ID: 14973778
[TBL] [Abstract][Full Text] [Related]
11. ALG11-CDG syndrome: Expanding the phenotype.
Haanpää MK; Ng BG; Gallant NM; Singh KE; Brown C; Kimonis V; Freeze HH; Muller EA
Am J Med Genet A; 2019 Mar; 179(3):498-502. PubMed ID: 30676690
[TBL] [Abstract][Full Text] [Related]
12. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
[TBL] [Abstract][Full Text] [Related]
13. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing.
Timal S; Hoischen A; Lehle L; Adamowicz M; Huijben K; Sykut-Cegielska J; Paprocka J; Jamroz E; van Spronsen FJ; Körner C; Gilissen C; Rodenburg RJ; Eidhof I; Van den Heuvel L; Thiel C; Wevers RA; Morava E; Veltman J; Lefeber DJ
Hum Mol Genet; 2012 Oct; 21(19):4151-61. PubMed ID: 22492991
[TBL] [Abstract][Full Text] [Related]
14. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.
Morava E; Vodopiutz J; Lefeber DJ; Janecke AR; Schmidt WM; Lechner S; Item CB; Sykut-Cegielska J; Adamowicz M; Wierzba J; Zhang ZH; Mihalek I; Stockler S; Bodamer OA; Lehle L; Wevers RA
Pediatrics; 2012 Oct; 130(4):e1034-9. PubMed ID: 22966035
[TBL] [Abstract][Full Text] [Related]
15. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie).
Kim S; Westphal V; Srikrishna G; Mehta DP; Peterson S; Filiano J; Karnes PS; Patterson MC; Freeze HH
J Clin Invest; 2000 Jan; 105(2):191-8. PubMed ID: 10642597
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.
Frank CG; Grubenmann CE; Eyaid W; Berger EG; Aebi M; Hennet T
Am J Hum Genet; 2004 Jul; 75(1):146-50. PubMed ID: 15148656
[TBL] [Abstract][Full Text] [Related]
17. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.
Yang AC; Ng BG; Moore SA; Rush J; Waechter CJ; Raymond KM; Willer T; Campbell KP; Freeze HH; Mehta L
Mol Genet Metab; 2013 Nov; 110(3):345-351. PubMed ID: 23856421
[TBL] [Abstract][Full Text] [Related]
18. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
19. SRD5A3-CDG: a patient with a novel mutation.
Kasapkara CS; Tümer L; Ezgü FS; Hasanoğlu A; Race V; Matthijs G; Jaeken J
Eur J Paediatr Neurol; 2012 Sep; 16(5):554-6. PubMed ID: 22240719
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
